Advertisement
UK markets open in 1 hour 59 minutes
  • NIKKEI 225

    38,030.93
    +402.45 (+1.07%)
     
  • HANG SENG

    17,626.75
    +342.21 (+1.98%)
     
  • CRUDE OIL

    83.84
    +0.27 (+0.32%)
     
  • GOLD FUTURES

    2,347.70
    +5.20 (+0.22%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,363.93
    -92.59 (-0.18%)
     
  • CMC Crypto 200

    1,387.27
    +4.69 (+0.34%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Is It Too Late to Buy Vaxart Stock?

Is It Too Late to Buy Vaxart Stock?

On June 11, Vaxart (NASDAQ: VXRT) stock skyrocketed 22% after Piper Sandler analyst Yasmeen Rahimi initiated coverage of the company with a price target of $18. In setting the price target, the analyst cited the validation of the company's novel adenoviral platform, Ad5, in 200 clinical studies. Vaxart is using the technology to develop a novel, pill-based oral coronavirus vaccine candidate.